Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2000
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047240A1 Methods of inactivating pathogens using broad-spectrum pulsed light
08/17/2000WO2000047238A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000047216A1 Immunogenic compositions for use as vaccines
08/17/2000WO2000047040A1 Growth medium for human corneal endothelial cells
08/17/2000WO2000033870A3 New cancer treatments
08/17/2000WO2000030675A3 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
08/17/2000WO2000016641A9 Interactions between genotype and diet in swine that prevent e coli associated intestinal disease
08/17/2000WO2000015765A9 Enhanced submucosal tissue graft constructs
08/17/2000WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
08/17/2000WO2000004930A3 Method for inactivation of microorganisms using photosensitizers
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000DE19905501A1 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament
08/17/2000CA2362593A1 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362377A1 Maturation of dendritic cells with immune response modifying compounds
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
08/17/2000CA2360292A1 Immunogenic compositions for use as vaccines
08/17/2000CA2360131A1 Methods of inactivating pathogens using broad-spectrum pulsed light
08/17/2000CA2359748A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
08/16/2000EP1027833A1 Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substances
08/16/2000EP1027371A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027069A1 Compositions and methods for treating lysosomal storage disease
08/16/2000EP1027063A1 Mannose receptor bearing cell line and antigen composition
08/16/2000EP1027014A1 Implantable system with drug-eluting cells for on-demand local drug delivery
08/16/2000EP0644929B1 System and method for transplantation of cells
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
08/16/2000CN1262955A Chinese medicine powder preparation for curing leukemia
08/16/2000CN1262954A Homothermal adhesive plaster promoting blood circulation to stop pain
08/16/2000CN1262950A Linjunsha medicine
08/16/2000CN1262948A Production method of gastric ulcer quickly-healing preparation
08/16/2000CN1262945A Preparation method of medicine Huanshen Xingnao Dan for curing encephalomyelopathy
08/16/2000CN1262944A Preparation method of medicine Huaqi Huannao Dan for curing encephalomyelopathy
08/16/2000CN1262937A Medicinal composition for curing and preventing urinary calculus
08/16/2000CN1262936A Medicine for curing psoriasis
08/16/2000CN1262935A Medicated wine for curing rheumatism and rheumatoid disease and its preparing method
08/16/2000CN1262933A Soluble granules for curing vitreous opacity and vitreous hemorrhage and preparation method thereof
08/16/2000CN1262932A Snake bone product and its production method
08/16/2000CN1262931A Method for extracting marine active substance and its application
08/16/2000CN1262930A Chinese medicine Lidanxiaodou liquor
08/16/2000CN1262872A Symbiotic functional food
08/16/2000CN1055410C Medicine for curing acute tonsillitis and upper respiratory tract infection and its preparing method
08/16/2000CN1055409C Medicine for curing complicated urinary tract infection
08/16/2000CN1055407C Method for preparing Chinese medicine for curing and preventing apoplexy
08/16/2000CN1055406C Prescription and preparation technology of sanula (Three-Deer) kidney-warming tonic wine
08/16/2000CN1055405C Capsule for curing thromboangitis
08/16/2000CN1055403C Medical ointment for treating scabies
08/16/2000CN1055401C Chinese patent drug for curing epilepsy
08/16/2000CN1055399C Acupoint application liquid for myopia
08/16/2000CN1055398C Medicament for curing hyerosteogeny, and its prepn. method
08/16/2000CN1055395C Liubao ecological oral liquid
08/16/2000CN1055394C Medicinal composition for treating postoperative syndrome of gallbladder
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103694 Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
08/15/2000US6103693 Method for isolation of highly pure von willebrand factor
08/15/2000US6103530 Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor
08/15/2000US6103521 Multispecific chimeric receptors
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103228 Antibiotic-producing and metabolite-producing bacillus subtilis strain that exhibits insecticidal activity
08/15/2000US6103227 Lactobacillus reuteri to inhibit cryptosporidiosis in mammals
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046385A1 Gene repair involving in vivo excision of targeting dna
08/10/2000WO2000046360A1 Improved helper dependent vector system for gene therapy
08/10/2000WO2000046355A2 Telomerase reverse transcriptase transcriptional regulatory sequences
08/10/2000WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof
08/10/2000WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000WO2000046351A2 Platform for the differentiation of cells
08/10/2000WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/10/2000WO2000046249A1 Method for producing il-1ra, a therapeutically active protein from body fluids
08/10/2000WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
08/10/2000WO2000046237A1 Brain-derived alkali-soluble immunoregulatory composition
08/10/2000WO2000045873A1 Methods and compositions for use in perfusion applications
08/10/2000WO2000045853A2 Treatment of tumors with genetically engineered herpes virus
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045842A2 Methods for human allografting
08/10/2000WO2000045837A1 Novel use within transplantation surgery
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/10/2000WO2000045827A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
08/10/2000WO2000025827A3 Dna molecules encoding muc-1 and use thereof in tumor vaccination
08/10/2000WO2000025810A3 Immunomodulatory factors for immunosuppressant and antiallergic treatment
08/10/2000WO1999006547A3 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
08/10/2000DE19904785A1 Verfahren zur Herstellung von stabilem Alginatmaterial Process for the preparation of stable alginate
08/10/2000DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/10/2000DE19903876A1 Verfahren zur Induktion von prophylaktisch oder therapeutisch wirksamen Proteinen Method of inducing a prophylactic or therapeutically effective proteins
08/10/2000CA2362231A1 Brain-derived alkali-soluble immunoregulatory composition
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2360878A1 Gene repair involving excision of targeting dna
08/10/2000CA2360796A1 Improved helper dependent vector system for gene therapy
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2359821A1 Platform for the differentiation of cells
08/10/2000CA2321107A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
1 ... 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 ... 1259